Pulmonary arterial hypertension (PAH), a common complication of systemic sclerosis, carries a very severe prognosis and is one of the leading causes of death in patients who suffer from it. Indeed, ...

When Amy was first diagnosed with scleroderma, she never imagined it would lead to a lifelong journey with lung disease.

Pulmonary hypertension (PAH) is a feared complication of scleroderma and a leading cause of mortality in this disease. In this study, Shah and colleagues evaluated the factors that could predict PAH ...

Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Pulmonary arterial hypertension’s prevalence and rate of progression in patients with connective ...

CLEVELAND — Every patient with systemic sclerosis should be screened for pulmonary arterial hypertension every year, as early recognition, referral and aggressive treatment are necessary to improve ...

Screening for a sometimes fatal condition among patients with a rare autoimmune disease could soon - thanks to a computer algorithm - become even more accurate. Researchers at Michigan Medicine found ...

More than 40,000 persons die each year in the US from pulmonary fibrosis, but the mortality rate among African-Americans is twice as high Caucasians. A physiologist from Belarus working at the Medical ...

Michigan: During a recent study, a Michigan Medicine researcher discovered a protein that can predict disease severity for a lung condition that often proves fatal for patients with scleroderma. The ...

Screening for a sometimes fatal condition among patients with a rare autoimmune disease could soon - thanks to a computer algorithm - become even more accurate. Researchers at Michigan Medicine found ...

A drug used to treat cancer may also be effective in diseases that cause scarring of the internal organs or skin, such as pulmonary fibrosis or scleroderma. The drug, with the generic name bortezomib, ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window WASHINGTON, July ...

A drug that is used to treat cancer may be equally effective in treating diseases that cause scarring of the internal organs or skin, such as pulmonary fibrosis or scleroderma. A drug that is used to ...